FDA.reportPublic FDA data

Enjaymo 1100 MG in 22 ML Injection

RxCUI
2591425
RxNorm name
Enjaymo 1100 MG in 22 ML Injection
Display name
Enjaymo 1100 MG in 22 ML Injection
Full name
Enjaymo 1100 MG in 22 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761164Enjaymosutimlimab-jome351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EnjaymoSUTIMLIMAB-JOMERecordati Rare Diseases, Inc.0a25363a-7781-d9f8-cb1c-be22987bf03b2026-03-02Warnings, Adverse reactionsExact identifier
rxcui: 2591425

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
281cf1d4-6296-4416-858e-9bff46d01b71Enjaymo 1100 MG in 22 ML InjectionPSN10These highlights do not include all the information needed to use ENJAYMO safely and effectively. See full prescribing information for ENJAYMO. ENJAYMO ® (sutimlimab-jome) injection, for intravenous use Initial U.S. Approval: 202220240221
281cf1d4-6296-4416-858e-9bff46d01b7122 ML Enjaymo 50 MG/ML InjectionSY10These highlights do not include all the information needed to use ENJAYMO safely and effectively. See full prescribing information for ENJAYMO. ENJAYMO ® (sutimlimab-jome) injection, for intravenous use Initial U.S. Approval: 202220240221
281cf1d4-6296-4416-858e-9bff46d01b71Enjaymo 1100 MG per 22 ML InjectionSY10These highlights do not include all the information needed to use ENJAYMO safely and effectively. See full prescribing information for ENJAYMO. ENJAYMO ® (sutimlimab-jome) injection, for intravenous use Initial U.S. Approval: 202220240221
281cf1d4-6296-4416-858e-9bff46d01b7122 ML sutimlimab-jome 50 MG/ML Injection [Enjaymo]SBD10These highlights do not include all the information needed to use ENJAYMO safely and effectively. See full prescribing information for ENJAYMO. ENJAYMO ® (sutimlimab-jome) injection, for intravenous use Initial U.S. Approval: 202220240221
0a25363a-7781-d9f8-cb1c-be22987bf03bEnjaymo 1100 MG per 22 ML InjectionSY4These highlights do not include all the information needed to use ENJAYMO safely and effectively. See full prescribing information for ENJAYMO. ENJAYMO ® (sutimlimab-jome) injection, for intravenous use Initial U.S. Approval: 202220260302
0a25363a-7781-d9f8-cb1c-be22987bf03b22 ML Enjaymo 50 MG/ML InjectionSY4These highlights do not include all the information needed to use ENJAYMO safely and effectively. See full prescribing information for ENJAYMO. ENJAYMO ® (sutimlimab-jome) injection, for intravenous use Initial U.S. Approval: 202220260302
0a25363a-7781-d9f8-cb1c-be22987bf03b22 ML sutimlimab-jome 50 MG/ML Injection [Enjaymo]SBD4These highlights do not include all the information needed to use ENJAYMO safely and effectively. See full prescribing information for ENJAYMO. ENJAYMO ® (sutimlimab-jome) injection, for intravenous use Initial U.S. Approval: 202220260302
0a25363a-7781-d9f8-cb1c-be22987bf03bEnjaymo 1100 MG in 22 ML InjectionPSN4These highlights do not include all the information needed to use ENJAYMO safely and effectively. See full prescribing information for ENJAYMO. ENJAYMO ® (sutimlimab-jome) injection, for intravenous use Initial U.S. Approval: 202220260302